Cargando…

Effects of miRNA-199a-5p on cell proliferation and apoptosis of uterine leiomyoma by targeting MED12

BACKGROUND/AIMS: Uterine leiomyoma (ULM) is a kind of gene-involved benign tumor, which is located in the front of female reproductive tract. It is one of the most common reproductive tract tumors in women, which leads to abnormal menstruation, repeated pregnancy loss, and other serious gynecologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wei, Zhao, Yingyan, Chen, Ling, Sun, Yan, Fan, Sumei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749127/ https://www.ncbi.nlm.nih.gov/pubmed/35071776 http://dx.doi.org/10.1515/med-2021-0348

Ejemplares similares

miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1
por: Zhao, Wei, et al.
Publicado: (2022)

MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
por: Kämpjärvi, Kati, et al.
Publicado: (2016)

Analysis of MED12 Mutation in Multiple Uterine Leiomyomas in South Korean patients
por: Lee, Minkyoung, et al.
Publicado: (2018)

Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas
por: Chuang, Tsai-Der, et al.
Publicado: (2023)

Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients
por: Mäkinen, Netta, et al.
Publicado: (2011)

MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma
por: Bertsch, Elizabeth, et al.
Publicado: (2014)

Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas
por: Mäkinen, N, et al.
Publicado: (2014)

Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women
por: Ajabnoor, Ghada M. A., et al.
Publicado: (2018)

Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status
por: Hutchinson, Anne P., et al.
Publicado: (2022)

MED12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas
por: Zuberi, Azna, et al.
Publicado: (2023)

Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas
por: McGuire, Megan M., et al.
Publicado: (2012)

Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas
por: Moyo, Mthabisi B., et al.
Publicado: (2020)

HMGA2 overexpression is associated with differential expression of miRNAs in uterine leiomyomas
por: Mello, Julia BH, et al.
Publicado: (2013)

Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma
por: Liu, Shimeng, et al.
Publicado: (2018)

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52
por: Chen, Hong, et al.
Publicado: (2016)

Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells
por: Lv, Shu-Lan, et al.
Publicado: (2020)

THU625 Med12 Mutation Activates Tryptophan-Kynurenine-ahr Pathway To Promote Growth Of Uterine Leiomyoma
por: Zuberi, Azna, et al.
Publicado: (2023)

Differential regulatory effect of progesterone on the proliferation and apoptosis of uterine leiomyoma tissue explants and primary leiomyoma cell cultures
por: Voronin, Dmitry, et al.
Publicado: (2021)

Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells
por: Lee, Hyun Gyo, et al.
Publicado: (2014)

miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Retraction]
Publicado: (2023)

Cytogenetically normal uterine leiomyomas without MED12-mutations – a source to identify unknown mechanisms of the development of uterine smooth muscle tumors
por: Holzmann, Carsten, et al.
Publicado: (2014)

Myometrial oxidative stress drives MED12 mutations in leiomyoma
por: Li, Yinuo, et al.
Publicado: (2022)

miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Expression of Concern]
Publicado: (2020)

LncRNA SRA1 may play a role in the uterine leiomyoma tumor growth regarding the MED12 mutation pattern
por: Akbari, Mojdeh, et al.
Publicado: (2019)

Bladder leiomyoma presenting as uterine pedunculated leiomyoma
por: Nazari, Zeinab, et al.
Publicado: (2022)

FANCA Polymorphism Is Associated with the Rate of Proliferation in Uterine Leiomyoma in Korea
por: Ha, Eunyoung, et al.
Publicado: (2020)

Uterine leiomyoma with tubules
por: Pusiol, Teresa, et al.
Publicado: (2008)

Uterine Leiomyomas: An ENIGMA
por: Geethamala, Kempula, et al.
Publicado: (2016)

Ultrasonography of uterine leiomyomas
por: Woźniak, Andrzej, et al.
Publicado: (2017)

Fisetin induces apoptosis in uterine leiomyomas through multiple pathways
por: Lee, Jin-Woo, et al.
Publicado: (2020)

Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth
por: Bloch, Jeannine, et al.
Publicado: (2017)

MiRNA-199a-3p Regulates C2C12 Myoblast Differentiation through IGF-1/AKT/mTOR Signal Pathway
por: Jia, Long, et al.
Publicado: (2013)

Pulmonary benign metastasizing leiomyoma from uterine leiomyoma
por: Chen, Sufeng, et al.
Publicado: (2013)

Primary Ovarian Leiomyoma Associated with Multiple Uterine Leiomyomas
por: Kitamura, Yoshihiro, et al.
Publicado: (2021)

Multiple cutaneous and uterine leiomyomas
por: Asilian, Ali, et al.
Publicado: (2013)

Malignant transformation of uterine leiomyoma
por: Al Ansari, Afaf A., et al.
Publicado: (2013)

Inhibiting effect of miR-29 on proliferation and migration of uterine leiomyoma via the STAT3 signaling pathway
por: Huang, Dai, et al.
Publicado: (2022)

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
por: Kämpjärvi, K, et al.
Publicado: (2012)

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fdtq338mhcdua5rm1cjn2hpb4c